Ceftazidime Avibactam Market, By Type (Combination (CAZ/AVI), Ceftazidime (CAZ), and Avibactam (AVI)), By Indication (Complicated intra-abdominal infections, Complicated urinary tract infections, Hospital-acquired bacterial pneumonia, Ventilator-associated bacterial pneumonia, Bloodstream infections caused by carbapenem-resistant organisms, and Other multidrug-resistant Gram-negative infections), By Dosage Form (Injectable, Powder for Reconstitution, and Pre-filled Syringes), By Drug Type (Branded and Generic), By End User (Tertiary-care hospitals, Secondary-care hospitals, Long-term acute-care facilities, and Specialized infectious disease centers), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), By Geography (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa) - Growth Trends and Forecasts (2025-2032)
Select a License Type that Suits your Business Needs
US$ 2,000
Two thousand dollars
Single User License
(1 User)
US$ 4,500
US$ 3,000
Three thousand dollars
Frequently Purchased
Multi User License
(Upto 7 Users)
US$ 7,000
US$ 5,000
Five thousand dollars
Corporate User License
(Unlimited Users)
US$ 10,000
US$ 6,000
Six thousand dollars
Client Testimonials
Client Testimonials
Our Clients
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients
Credibility and Certifications
Trusted Insights, Certified Excellence! Coherent Market Insights is a certified data advisory and business consulting firm recognized by global institutes.

860519526
9001:2015
27001:2022